Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disorder worldwide. The pathological spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) that induces progressive liver cirrhosis and eventually hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Juqiang, Zhang, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358116/
https://www.ncbi.nlm.nih.gov/pubmed/34395461
http://dx.doi.org/10.3389/fmed.2021.653293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358116/
https://www.ncbi.nlm.nih.gov/pubmed/34395461
http://dx.doi.org/10.3389/fmed.2021.653293

Ejemplares similares